BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3524816)

  • 1. Role of monocyte cytotoxic factor in cytolysis of actinomycin D-treated WEHI 164 cells mediated by freshly isolated human adherent mononuclear blood cells.
    Austgulen R; Espevik T; Hammerstrøm J; Nissen-Meyer J
    Cancer Res; 1986 Sep; 46(9):4566-70. PubMed ID: 3524816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
    Ziegler-Heitbrock HW; Möller A; Linke RP; Haas JG; Rieber EP; Riethmüller G
    Cancer Res; 1986 Nov; 46(11):5947-52. PubMed ID: 3756932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.
    Chen AR; McKinnon KP; Koren HS
    J Immunol; 1985 Dec; 135(6):3978-87. PubMed ID: 3905966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
    Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R
    Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin.
    Kornbluth RS; Edgington TS
    J Immunol; 1986 Oct; 137(8):2585-91. PubMed ID: 3760568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
    Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
    J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monocyte cytotoxic factor mediates cytolysis of WEHI 164 cells.
    Austgulen R; Hammerstrøm J; Espevik T; Nissen-Meyer J
    Cell Immunol; 1986 Mar; 98(1):211-20. PubMed ID: 3461886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytolysis of actinomycin D-treated target cells by cell-free supernatants from human monocytes.
    McKinnon KP; Chen AR; Argov S; Lane BC; Koren HS
    Immunobiology; 1986 Mar; 171(1-2):27-44. PubMed ID: 3710517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of monocyte cytotoxic factor in monocyte-mediated lysis of tumour cells.
    Espevik T; Kildahl-Andersen O; Nissen-Meyer J
    Immunology; 1986 Feb; 57(2):255-9. PubMed ID: 3081437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor in human monocyte-mediated antitumor cytotoxicity.
    Ziegler-Heitbrock HW; Thiel C; Haas JG; Möller A; Riethmüller G
    Nat Immun Cell Growth Regul; 1988; 7(5-6):280-6. PubMed ID: 3221906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of tumour necrosis factor in monocyte-mediated rapid killing of actinomycin D-pretreated WEHI 164 sarcoma cells.
    Bersani L; Colotta F; Mantovani A
    Immunology; 1986 Oct; 59(2):323-5. PubMed ID: 3770807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Production and function of the monocyte cytotoxic factor (MCF)].
    Uchida A
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2098-104. PubMed ID: 2440386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antisera against recombinant tumor necrosis factor and the monocyte-derived cytotoxin(s) on monocyte-mediated killing of various tumor cells.
    Nissen-Meyer J; Espevik T
    Cell Immunol; 1987 Oct; 109(2):384-96. PubMed ID: 3478143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of monocyte cytotoxic factor (CF) in cytostasis mediated by IFN-gamma-activated monocytes.
    Kildahl-Andersen O; Nissen-Meyer J
    Immunology; 1985 Oct; 56(2):367-72. PubMed ID: 3932193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic effector function of B lymphoblasts.
    Bersani L; Colotta F; Peri G; Mantovani A
    J Immunol; 1987 Jul; 139(2):645-8. PubMed ID: 3496385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte-mediated drug-dependent cellular cytotoxicity: effects on different WEHI 164 target cell lines.
    Austgulen R; Kildahl-Andersen O; Espevik T
    Cancer Immunol Immunother; 1986; 22(3):176-80. PubMed ID: 3731202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels.
    Calderon TM; Factor SM; Hatcher VB; Berliner JA; Berman JW
    Lab Invest; 1994 Jun; 70(6):836-49. PubMed ID: 8015288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.
    Espevik T; Nissen-Meyer J
    J Immunol Methods; 1986 Dec; 95(1):99-105. PubMed ID: 3782828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of recombinant tumor necrosis factor and the monocyte-derived cytotoxic factor involved in monocyte-mediated cytotoxicity.
    Nissen-Meyer J; Austgulen R; Espevik T
    Cancer Res; 1987 May; 47(9):2251-8. PubMed ID: 3567918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.